ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/08 | 2,250 | 2,309 | 2,230 | 2,307 | +74 | +3.3% | 126,200 |
2018/05/07 | 2,236 | 2,239 | 2,200 | 2,233 | +2 | +0.1% | 38,900 |
2018/05/02 | 2,240 | 2,240 | 2,199 | 2,231 | -8 | -0.4% | 30,900 |
2018/05/01 | 2,251 | 2,251 | 2,228 | 2,239 | -10 | -0.4% | 34,300 |
2018/04/27 | 2,248 | 2,261 | 2,230 | 2,249 | +18 | +0.8% | 63,600 |
2018/04/26 | 2,216 | 2,235 | 2,192 | 2,231 | +10 | +0.5% | 55,000 |
2018/04/25 | 2,200 | 2,241 | 2,198 | 2,221 | +8 | +0.4% | 96,900 |
2018/04/24 | 2,200 | 2,220 | 2,185 | 2,213 | +19 | +0.9% | 87,200 |
2018/04/23 | 2,200 | 2,202 | 2,178 | 2,194 | +2 | +0.1% | 28,300 |
2018/04/20 | 2,181 | 2,203 | 2,181 | 2,192 | +1 | ±0% | 44,100 |
2018/04/19 | 2,198 | 2,203 | 2,170 | 2,191 | -11 | -0.5% | 59,300 |
2018/04/18 | 2,194 | 2,208 | 2,183 | 2,202 | +8 | +0.4% | 48,500 |
2018/04/17 | 2,200 | 2,207 | 2,185 | 2,194 | +6 | +0.3% | 45,500 |
2018/04/16 | 2,155 | 2,191 | 2,137 | 2,188 | +53 | +2.5% | 43,600 |
2018/04/13 | 2,176 | 2,182 | 2,123 | 2,135 | -30 | -1.4% | 62,800 |
2018/04/12 | 2,182 | 2,194 | 2,159 | 2,165 | -21 | -1% | 55,200 |
2018/04/11 | 2,217 | 2,217 | 2,162 | 2,186 | -22 | -1% | 71,200 |
2018/04/10 | 2,200 | 2,236 | 2,186 | 2,208 | -1 | ±0% | 116,200 |
2018/04/09 | 2,189 | 2,230 | 2,189 | 2,209 | +28 | +1.3% | 95,400 |
2018/04/06 | 2,168 | 2,187 | 2,140 | 2,181 | +15 | +0.7% | 88,600 |
2018/04/05 | 2,162 | 2,180 | 2,148 | 2,166 | +22 | +1% | 73,800 |
2018/04/04 | 2,103 | 2,149 | 2,095 | 2,144 | +29 | +1.4% | 96,700 |
2018/04/03 | 2,096 | 2,122 | 2,079 | 2,115 | +8 | +0.4% | 62,700 |
2018/04/02 | 2,129 | 2,139 | 2,101 | 2,107 | -21 | -1% | 57,000 |
2018/03/30 | 2,160 | 2,160 | 2,105 | 2,128 | -2 | -0.1% | 58,300 |
2018/03/29 | 2,130 | 2,142 | 2,088 | 2,130 | +10 | +0.5% | 111,700 |
2018/03/28 | 2,086 | 2,122 | 2,064 | 2,120 | +1 | ±0% | 111,500 |
2018/03/27 | 2,034 | 2,120 | 2,029 | 2,119 | +100 | +5% | 195,600 |
2018/03/26 | 2,009 | 2,022 | 1,998 | 2,019 | +10 | +0.5% | 198,400 |
2018/03/23 | 2,001 | 2,026 | 2,001 | 2,009 | -33 | -1.6% | 191,200 |
2018/03/22 | 2,029 | 2,044 | 2,005 | 2,042 | +21 | +1% | 98,900 |
2018/03/20 | 2,020 | 2,035 | 2,004 | 2,021 | ±0 | ±0% | 90,300 |
2018/03/19 | 2,017 | 2,026 | 2,001 | 2,021 | -3 | -0.1% | 60,400 |
2018/03/16 | 2,059 | 2,059 | 2,022 | 2,024 | -17 | -0.8% | 74,100 |
2018/03/15 | 2,075 | 2,075 | 2,033 | 2,041 | -19 | -0.9% | 46,600 |
2018/03/14 | 2,084 | 2,084 | 2,047 | 2,060 | -27 | -1.3% | 78,300 |
2018/03/13 | 2,040 | 2,089 | 2,036 | 2,087 | +47 | +2.3% | 64,100 |
2018/03/12 | 2,049 | 2,049 | 2,027 | 2,040 | +15 | +0.7% | 48,200 |
2018/03/09 | 2,050 | 2,050 | 2,011 | 2,025 | +7 | +0.3% | 127,500 |
2018/03/08 | 2,062 | 2,062 | 2,009 | 2,018 | -1 | ±0% | 39,300 |
2018/03/07 | 2,021 | 2,052 | 2,012 | 2,019 | -4 | -0.2% | 51,800 |
2018/03/06 | 2,034 | 2,050 | 2,018 | 2,023 | +2 | +0.1% | 55,200 |
2018/03/05 | 2,018 | 2,033 | 2,006 | 2,021 | +1 | ±0% | 56,800 |
2018/03/02 | 2,046 | 2,061 | 2,010 | 2,020 | -58 | -2.8% | 91,000 |
2018/03/01 | 2,091 | 2,097 | 2,071 | 2,078 | -18 | -0.9% | 103,400 |
2018/02/28 | 2,112 | 2,130 | 2,096 | 2,096 | -31 | -1.5% | 79,600 |
2018/02/27 | 2,150 | 2,150 | 2,116 | 2,127 | -14 | -0.7% | 47,400 |
2018/02/26 | 2,130 | 2,147 | 2,125 | 2,141 | +33 | +1.6% | 43,100 |
2018/02/23 | 2,117 | 2,117 | 2,093 | 2,108 | -1 | ±0% | 54,500 |
2018/02/22 | 2,091 | 2,112 | 2,075 | 2,109 | -1 | ±0% | 96,000 |
1601~
1650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 226,500円 | +13.6% | +29.2% | 2.03% | 11.75倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 481,000円 | +12.0% | +28.1% | 2.49% | 26.52倍 | 1.12倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 333,500円 | +3.0% | +27.5% | 2.40% | 21.12倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 112,900円 | +197.7% | - | 0.00% | 46.14倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 150,200円 | +3.2% | +4.5% | 3.46% | 17.25倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム